Welcome to LookChem.com Sign In|Join Free
  • or
1,3β,4α-Trihydroxy-5-oxocyclohexane-1β-carboxylic acid, also known as 3-Dehydroquinate, is an important intermediate in the shikimate pathway, a metabolic pathway found in bacteria, fungi, and plants. It is a cyclohexane derivative with three hydroxyl groups and one carboxylic acid group, and it plays a crucial role in the biosynthesis of aromatic amino acids and other secondary metabolites.
Used in Metabolic Engineering:
1,3β,4α-Trihydroxy-5-oxocyclohexane-1β-carboxylic acid is used as a target for metabolic engineering in microorganisms, such as Escherichia coli, for the production of valuable compounds like aromatic amino acids and other secondary metabolites. By manipulating the enzymes and regulatory elements involved in the shikimate pathway, researchers can enhance the production of desired compounds and improve the overall efficiency of the metabolic process.
Used in Synthetic Biology:
1,3β,4α-Trihydroxy-5-oxocyclohexane-1β-carboxylic acid is used as a building block in synthetic biology for the design and construction of novel biosynthetic pathways. By incorporating 1,3β,4α-Trihydroxy-5-oxocyclohexane-1β-carboxylic acid into engineered metabolic pathways, scientists can create new biosynthetic routes for the production of valuable chemicals, pharmaceuticals, and other bioproducts.
Used in Enzyme Inhibition:
1,3β,4α-Trihydroxy-5-oxocyclohexane-1β-carboxylic acid is used as an inhibitor of key enzymes in the shikimate pathway, such as 3-deoxy-D-arabino-heptulosonate 7-phosphate (DAHP) synthase. By inhibiting these enzymes, researchers can study the regulation and control of the shikimate pathway and develop new strategies for the control of microbial growth and the production of secondary metabolites.
Used in Drug Discovery:
1,3β,4α-Trihydroxy-5-oxocyclohexane-1β-carboxylic acid is used as a lead compound in drug discovery for the development of new antimicrobial agents. By targeting the shikimate pathway, which is essential for the biosynthesis of aromatic amino acids in many pathogens, researchers can identify novel inhibitors that can be used as potential therapeutic agents against bacterial and fungal infections.
Used in Biosensors:
1,3β,4α-Trihydroxy-5-oxocyclohexane-1β-carboxylic acid is used in the development of synthetic biosensors for metabolite monitoring and genetic screening in microorganisms. By engineering biosensors that respond to changes in the levels of 1,3β,4α-Trihydroxy-5-oxocyclohexane-1β-carboxylic acid, researchers can gain insights into the regulation of the shikimate pathway and identify potential targets for metabolic engineering and drug discovery.

10534-44-8

Post Buying Request

10534-44-8 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

10534-44-8 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 10534-44-8 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,0,5,3 and 4 respectively; the second part has 2 digits, 4 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 10534-44:
(7*1)+(6*0)+(5*5)+(4*3)+(3*4)+(2*4)+(1*4)=68
68 % 10 = 8
So 10534-44-8 is a valid CAS Registry Number.
InChI:InChI=1/C7H10O6/c8-3-1-7(13,6(11)12)2-4(9)5(3)10/h3,5,8,10,13H,1-2H2,(H,11,12)

10534-44-8SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 17, 2017

Revision Date: Aug 17, 2017

1.Identification

1.1 GHS Product identifier

Product name 3-dehydroquinic acid

1.2 Other means of identification

Product number -
Other names .(1R)-1,3c,4t-Trihydroxy-5-oxo-cyclohexan-r-carbonsaeure

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:10534-44-8 SDS

10534-44-8Relevant academic research and scientific papers

Creation of a shikimate pathway variant

Ran, Ningqing,Draths,Frost

, p. 6856 - 6857 (2004)

The competition between the Escherichia coli carbohydrate phosphotransferase system and 3-deoxy-d-arabino-heptulosonate 7-phosphate (DAHP) synthase for phosphoenolpyruvate limits the concentration and yield of natural products microbially synthesized via the shikimate pathway. To circumvent this competition for phosphoenolpyruvate, a shikimate pathway variant has been created. 2-Keto-3-deoxy-6-phosphogalactonate (KDPGal) aldolases encoded by Escherichia coli dgoA and Klebsiella pneumoniae dgoA are subjected to directed evolution. The evolved KDPGal aldolase isozymes exhibit 4-8-fold higher specific activities relative to that for native KDPGal aldolase with respect to catalyzing the condensation of pyruvate and d-erythrose 4-phosphate to produce DAHP. To probe the ability of the created shikimate pathway variant to support microbial growth and metabolism, growth rates and synthesis of 3-dehydroshikimate are examined for E. coli constructs that lack phosphoenolpruvate-based DAHP synthase activity and rely on evolved KDPGal aldolase for biosynthesis of shikimate pathway intermediates and products. Copyright

A convenient method for the synthesis of dehydroquinic acid

Le Sann, Christine,Abell, Chris,Abell, Andrew D.

, p. 527 - 533 (2003)

A convenient synthesis of dehydroquinic acid and its corresponding methyl ester are described. Protection of the trans diol of quinic acid, followed by PCC oxidation, gave fully protected dehydroquinic acid. This gave methyl dehydroquinate on mild acid ca

3-dehydroquinate production by oxidative fermentation and further conversion of 3-dehydroquinate to the intermediates in the shikimate pathway.

Adachi, Osao,Tanasupawat, Somboon,Yoshihara, Nozomi,Toyama, Hirohide,Matsushita, Kazunobu

, p. 2124 - 2131 (2003)

3-Dehydroquinate production from quinate by oxidative fermentation with Gluconobacter strains of acetic acid bacteria was analyzed for the first time. In the bacterial membrane, quinate dehydrogenase, a typical quinoprotein containing pyrroloquinoline qui

A thermodynamic study of the reactions: {2-dehydro-3-deoxy-D-arabino-heptanoate 7-phosphate(aq) = 3-dehydroquinate(aq) + phosphate(aq)} and {3-dehydroquinate(aq) = 3-dehydroshikimate(aq) + H2O(l)}

Tewari, Yadu B.,Goldberg, Robert N.,Hawkins, Alastair R.,Lamb, Heather K.

, p. 1671 - 1691 (2002)

Microcalorimetry and high-performance liquid chromatography (h.p.l.c.) have been used to conduct a thermodynamic investigation of reactions catalyzed by 3-dehydroquinate synthase and by 3-dehydroquinate dehydratase. These are the second and third reactions in the metabolic pathway leading to the formation of chorismate. The two reactions are: {DAHP(aq) = 3-dehydroquinate(aq) + phosphate(aq)} and {3-dehydroquinate(aq) = 3-dehydroshikimate(aq) + H2O(l)}. The h.p.l.c. measurements showed that the first reaction proceeded to completion and that the value of the apparent equilibrium constant for the second reaction was K′ = (4.6 ± 1.5) (Hepes buffer, temperature T = 298.15 K, pH = 7.50, and ionic strength Im = 0.065 mol·kg-1). Calorimetric measurements led to a molar enthalpy of reaction ΔrHm (cal) = -(50.9 ± 1.1) kJ·mol-1 (Hepes buffer, T = 298.15 K, pH = 7.46, Im = 0.070 mol·kg-1) for the first reaction and to ΔrHm (cal) = (2.3 ± 2.3) kJ·mol-1 (Hepes buffer, T = 298.15 K, pH = 7.42, Im = 0.069 mol·kg-1) for the second reaction. These results were analyzed in terms of a chemical equilibrium model that accounts for the multiplicity of ionic states of the reactants and products. These calculations gave thermodynamic quantities at T = 298.15 K and Im = 0 for chemical reference reactions involving specific ionic forms. For the reaction DAHP3-(aq) = 3-dehydroquinate-(aq) + HPO42-(aq), the standard molar enthalpy of reaction ΔrHmo = -(51.1 ± 4.5) kJ·mol-1. For the reaction 3-de-hydroquinate(aq) = (3-dehydroshikimate(aq) + H2O(l), the equilibrium constant K = (4.6 ± 1.5) and ΔrHmo = (2.3 ± 2.3) kJ·mol-1. A Benson type approach was used to estimate the standard molar entropy change ΔrSmo for the first reference reaction and led to the value K ≈ 2·1014 for this reaction. Values of the apparent equilibrium constants and the standard transformed Gibbs free energy changes ΔrGmo under approximately physiological conditions are given for the biochemical reactions.

Purification and characterization of membrane-bound quinoprotein quinate dehydrogenase

Adachi, Osao,Yoshihara, Nozomi,Tanasupawat, Somboon,Toyama, Hirohide,Matsushita, Kazunobu

, p. 2115 - 2123 (2003)

Several bacterial strains carrying quinoprotein quinate dehydrogenase (QDH) were screened through acetic acid bacteria and other bacteria. Strong enzyme activity was found in the membrane fraction of Gluconobacter melanogenus IFO 3294, G. oxydans IFO 3292

High shikimate production from quinate with two enzymatic systems of acetic acid bacteria

Adachi, Osao,Ano, Yoshitaka,Toyama, Hirohide,Matsushita, Kazunobu

, p. 2579 - 2582 (2006)

3-Dehydroshikimate was formed with a yield of 57-77% from quinate via 3-dehydroquinate by two successive enzyme reactions, quinoprotein quinate dehydrogenase (QDH) and 3-dehydroquinate dehydratase, in the cytoplasmic membranes of acetic acid bacteria. 3-Dehydroshikimate was then reduced to shikimate (SKA) with NADP-dependent SKA dehydrogenase (SKDH) from the same organism. When SKDH was coupled with NADP-dependent D-glucose dehydrogenase (GDH) in the presence of excess D-glucose as an NADPH regenerating system, SKDH continued to produce SKA until 3-dehydroshikimate added initially in the reaction mixture was completely converted to SKA. Based on the data presented, a strategy for high SKA production was proposed.

A simple method for the preparation of 3-hydroxyiminodehydroquinate, a potent inhibitor of type II dehydroquinase

Sann, Christine Le,Abell, Chris,Abell, Andrew D.

, p. 2065 - 2068 (2007/10/03)

A number of routes to 3-hydroxyiminodehydroquinate 4, one of the most potent inhibitors of type II dehydroquinase that is currently known, have been investigated. Methods based on the existing literature synthesis, i.e. oxime formation of a suitably C-4 a

Stereoselectivity in Nucleophilic Additions to the Carbonyl Group of Methyl 1,4,5-tris(trimethylsilyl)-3-dehydroquinate

Despeyroux, Pierre,Baltas, Michel,Gorrichon, Liliane

, p. 777 - 784 (2007/10/03)

Methyl 1,4,5-tris(trimethylsilyl)-3-dehydroquinate was synthesized in a three-step procedure and condensed with various nucleophiles (-CH2COOEt, -CH2SO2Ph, -CH2-CCH, H-).The diastereoselectivity of the reaction, leading to the creation of a new quaternary (or tetiary) asymmetric carbon atom was examined.The preferential axial attack on the C=O group of the cyclohexanone system is discussed.The deprotected products were evaluated as DHQase inhibitors. - Keywords: methyl 3-dehydroquinate; nucleophilic addition; diastereoselectivity.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 10534-44-8